THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Stacy Hussong to Animals

This is a "connection" page, showing publications Stacy Hussong has written about Animals.
Connection Strength

0.316
  1. Soluble pathogenic tau enters brain vascular endothelial cells and drives cellular senescence and brain microvascular dysfunction in a mouse model of tauopathy. Nat Commun. 2023 Apr 25; 14(1):2367.
    View in: PubMed
    Score: 0.081
  2. A novel role for the immunoproteasome in retinal function. Invest Ophthalmol Vis Sci. 2011 Feb; 52(2):714-23.
    View in: PubMed
    Score: 0.035
  3. Immunoproteasome deficiency alters retinal proteasome's response to stress. J Neurochem. 2010 Jun; 113(6):1481-90.
    View in: PubMed
    Score: 0.032
  4. mTOR Attenuation with Rapamycin Reverses Neurovascular Uncoupling and Memory Deficits in Mice Modeling Alzheimer's Disease. J Neurosci. 2021 05 12; 41(19):4305-4320.
    View in: PubMed
    Score: 0.018
  5. Primary neuron and astrocyte cultures from postnatal Callithrix jacchus: a non-human primate in vitro model for research in neuroscience, nervous system aging, and neurological diseases of aging. Geroscience. 2021 02; 43(1):115-124.
    View in: PubMed
    Score: 0.017
  6. mTOR drives cerebrovascular, synaptic, and cognitive dysfunction in normative aging. Aging Cell. 2020 01; 19(1):e13057.
    View in: PubMed
    Score: 0.016
  7. Inborn Errors of RNA Lariat Metabolism in Humans with Brainstem Viral Infection. Cell. 2018 02 22; 172(5):952-965.e18.
    View in: PubMed
    Score: 0.014
  8. Inhibition of mTOR protects the blood-brain barrier in models of Alzheimer's disease and vascular cognitive impairment. Am J Physiol Heart Circ Physiol. 2018 04 01; 314(4):H693-H703.
    View in: PubMed
    Score: 0.014
  9. mTOR drives cerebral blood flow and memory deficits in LDLR-/- mice modeling atherosclerosis and vascular cognitive impairment. J Cereb Blood Flow Metab. 2018 01; 38(1):58-74.
    View in: PubMed
    Score: 0.013
  10. Immunoproteasome deficiency protects in the retina after optic nerve crush. PLoS One. 2015; 10(5):e0126768.
    View in: PubMed
    Score: 0.012
  11. Retinal dendritic cell recruitment, but not function, was inhibited in MyD88 and TRIF deficient mice. J Neuroinflammation. 2014 Aug 13; 11:143.
    View in: PubMed
    Score: 0.011
  12. Decreased in vitro mitochondrial function is associated with enhanced brain metabolism, blood flow, and memory in Surf1-deficient mice. J Cereb Blood Flow Metab. 2013 Oct; 33(10):1605-11.
    View in: PubMed
    Score: 0.010
  13. Chronic rapamycin restores brain vascular integrity and function through NO synthase activation and improves memory in symptomatic mice modeling Alzheimer's disease. J Cereb Blood Flow Metab. 2013 Sep; 33(9):1412-21.
    View in: PubMed
    Score: 0.010
  14. Over-expression of heat shock factor 1 phenocopies the effect of chronic inhibition of TOR by rapamycin and is sufficient to ameliorate Alzheimer's-like deficits in mice modeling the disease. J Neurochem. 2013 Mar; 124(6):880-93.
    View in: PubMed
    Score: 0.010
  15. Chronic inhibition of mammalian target of rapamycin by rapamycin modulates cognitive and non-cognitive components of behavior throughout lifespan in mice. Neuroscience. 2012 Oct 25; 223:102-13.
    View in: PubMed
    Score: 0.010
  16. Immunoproteasome responds to injury in the retina and brain. J Neurochem. 2008 Jul; 106(1):158-69.
    View in: PubMed
    Score: 0.007
  17. Transformation of the proteasome with age-related macular degeneration. FEBS Lett. 2007 Mar 06; 581(5):885-90.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES